Home » Topics » Regulatory » Patents

Patents
RSS

Abbisko Therapeutics discloses new CSF-1R inhibitors

Jan. 16, 2019

Shanghai Institute of Materia Medica describes new antibacterials

Jan. 16, 2019

Deubiquitylating enzyme inhibitors discovered at Mission Therapeutics

Jan. 16, 2019

Complutense University of Madrid, University of Santiago de Compostela patent DRD1 PAMs

Jan. 16, 2019

Accro Bioscience patents necrosis inhibitors

Jan. 15, 2019

City of Hope National Medical Center discovers poly(ADP-ribose) glycohydrolase inhibitors

Jan. 15, 2019

Hampton University, the University of Virginia describe labeled thymidine compounds

Jan. 14, 2019

New multitargeted PARP, PI3K and/or BRD4 inhibitors disclosed by SignalRx Pharmaceuticals

Jan. 14, 2019

Novartis presents lysine-specific histone demethylase 1A inhibitors

Jan. 14, 2019

2-Acylglycerol O-acyltransferase 2 inhibitors identified at Shionogi

Jan. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...